Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab vs Low-Dose rATG in Kidney Transplant
NCT03006419Phase 4Completed
- Sponsor
- Coordinación de Investigación en Salud
- Start
- Dec 2016
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin rabbit in kidney transplant rejection, sponsored by Coordinación de Investigación en Salud. Started Dec 2016; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT03006419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006419.